Journal of Hypertension and Cardiology

論文を投稿する
English | 日本語
最新号 · 査読付き · オープンアクセス

最新号

JHCに掲載された、査読済みの最新の高血圧・循環器研究です。

第3巻 第4号 3本の論文 最新掲載 2025年12月 ISSN 2329-9487
49本のオープンアクセス論文
3巻
2013年から刊行
Crossref永続的なDOI
CC BY著作権は著者が保持
本号の内容

第3巻 第4号

すべての論文はCC BY 4.0のもとでオープンアクセスとして公開され、恒久的なCrossref DOIが付与されています。要旨は著者が作成したものです。各タイトルから全文、PDF、XMLをご覧いただけます。

研究成果であり、医学的助言ではありません。 Journal of Hypertension and Cardiologyは査読済みの科学研究を掲載しています。論文は学術および専門的な利用を目的としたものであり、個々の臨床判断や医学的助言に代わるものではありません。

  1. 研究論文

    Efficacy and Safety of Lercanidipine Combination in Hypertensive Patients参考訳:高血圧患者におけるレルカニジピン併用療法の有効性と安全性

    Athanasios J. Manolis, Manolis S. KallistratosORCID 0000-0002-8256-4218責任著者, Miguel CamafortORCID 0000-0002-8669-6410, Antonio Coca

    種別
    研究論文
    掲載日
    ページ
    38-49
    要旨(Efficacy and Safety of Lercanidipine Combination in Hypertensive Patients)

    Calcium channel blockers (CCBs) are widely used for the treatment of arterial hypertension, but they differ in terms of pharmacology, tolerability, and pleiotropic actions. Lercanidipine, a highly lipophilic third generation dihydropyridine, reduces blood pressure (BP) effectively as monotherapy and in combination without inferiority to other major antihypertensive classes. We systematically searched PubMed and the Cochrane Library (last update: September 1, 2025) and screened reference lists for additional studies. Evidence from dose finding trials, randomized controlled studies, large observational cohorts, and meta analyses shows clinically meaningful reductions in office, home, and ambulatory BP with lercanidipine, including in patients with diabetes, obesity, chronic kidney disease, or high cardiovascular (CV) risk. Fixed-dose combinations with renin angiotensin system blockers (e.g., enalapril) provide greater BP reductions than monotherapy and are associated with favorable neurometabolic profiles. Beyond BP control, lercanidipine improves central hemodynamics and arterial stiffness, favors endothelial biology, and contributes to left ventricular hypertrophy regression. Across comparative trials, lercanidipine is generally better tolerated than older dihydropyridines, with lower rates of vasodilatory adverse events and less sympathetic activation, while discontinuations due to adverse events are uncommon. Overall, lercanidipine, particularly within single-pill combinations, offers effective, durable BP lowering across diverse patient profiles with a favorable safety and tolerability profile and pleiotropic benefits that extend beyond BP reduction.

    引用方法
    Athanasios J. Manolis, Manolis S. Kallistratos, Miguel Camafort, Antonio Coca (2025). Efficacy and Safety of Lercanidipine Combination in Hypertensive Patients. Journal of Hypertension and Cardiology, 3(4), 38-49. https://doi.org/10.14302/issn.2329-9487.jhc-25-5778
    DOIからアクセス ↗
    RIS/BibTeXを表示
    TY  - JOUR
    AU  - Athanasios J. Manolis
    AU  - Manolis S. Kallistratos
    AU  - Miguel Camafort
    AU  - Antonio Coca
    TI  - Efficacy and Safety of Lercanidipine Combination in Hypertensive Patients
    JO  - Journal of Hypertension and Cardiology
    SN  - 2329-9487
    VL  - 3
    IS  - 4
    SP  - 38
    EP  - 49
    PY  - 2025
    DA  - 2025-12-02
    DO  - 10.14302/issn.2329-9487.jhc-25-5778
    UR  - https://doi.org/10.14302/issn.2329-9487.jhc-25-5778
    PB  - Open Access Pub
    ER  - 
    @article{jhc2267,
      author  = {Athanasios J. Manolis and Manolis S. Kallistratos and Miguel Camafort and Antonio Coca},
      title   = {Efficacy and Safety of Lercanidipine Combination in Hypertensive Patients},
      journal = {Journal of Hypertension and Cardiology},
      volume  = {3},
      number  = {4},
      pages   = {38--49},
      year    = {2025},
      issn    = {2329-9487},
      doi     = {10.14302/issn.2329-9487.jhc-25-5778},
      url     = {https://doi.org/10.14302/issn.2329-9487.jhc-25-5778}
    }
  2. 研究論文

    Prevalence of Hypertension Among Adolescents in Benue South, Nigeria参考訳:ナイジェリア・ベヌエ南部(Benue South)の青年期の若者における高血圧の有病率

    Rose Okwunu Abah責任著者, Daniel Ejeh UkpabiORCID 0000-0002-5922-6157, Juliana Ajuma Okoko

    種別
    研究論文
    掲載日
    ページ
    27-37
    DOI
    10.14302/issn.2329-9487.jhc-25-5726
    要旨(Prevalence of Hypertension Among Adolescents in Benue South, Nigeria)

    Background

    Hypertension in adolescents has been shown to track into adulthood, as well as causing premature cardiovascular and renal diseases.

    Objectives

    To determine the prevalence of elevated blood pressure and hypertension among adolescents of ages 10-19 years old attending secondary schools in Benue South, Nigeria; characterise their demographics and determine factors associated with the development of high blood pressure.

    Materials and Methods

    A cross-sectional descriptive study of secondary school adolescents selected through multistage sampling from across three Local Government Areas of Benue South, Nigeria. All the participants had their blood pressure measured using a mercury sphygmomanometer and their height and weight taken for the calculation of their body mass index. A dipstick urinalysis was carried out on their urine samples. Data analysis was with SPSS version 25.

    結果

    A total of 260 adolescents were studied, males were 132 (50.8%) and the mean age was 13.65 ± 2.01 years. The prevalence of elevated blood pressure and hypertension was 5.4% and 2.3% respectively. Fifteen females (75.0%) had elevated blood pressure/hypertension as against five males (25%) and it was statistically significant. Adolescents in mid-adolescence age (60.0%) and lower social class (70.0%) had higher rate of high blood pressure. Significant proteinuria (+) was found among eleven (55.0%) of those with high blood pressure.

    結論

    The prevalence of elevated blood pressure and hypertension among the adolescents was 5.4% and 2.3% respectively; being female, within mid-adolescence age and from lower social class are associated factors.

    推奨判定

    Regular blood pressure measurement should be part of the school health programme.

    引用方法
    Rose Okwunu Abah, Daniel Ejeh Ukpabi, Juliana Ajuma Okoko (2025). Prevalence of Hypertension Among Adolescents in Benue South, Nigeria. Journal of Hypertension and Cardiology, 3(4), 27-37. 10.14302/issn.2329-9487.jhc-25-5726
    RIS/BibTeXを表示
    TY  - JOUR
    AU  - Rose Okwunu Abah
    AU  - Daniel Ejeh Ukpabi
    AU  - Juliana Ajuma Okoko
    TI  - Prevalence of Hypertension Among Adolescents in Benue South, Nigeria
    JO  - Journal of Hypertension and Cardiology
    SN  - 2329-9487
    VL  - 3
    IS  - 4
    SP  - 27
    EP  - 37
    PY  - 2025
    DA  - 2025-10-18
    DO  - 10.14302/issn.2329-9487.jhc-25-5726
    UR  - https://openaccesspub.org/hypertension-and-cardiology/article/prevalence-of-hypertension-among-adolescents-in-benue-south-nigeria-2229
    PB  - Open Access Pub
    ER  - 
    @article{jhc2229,
      author  = {Rose Okwunu Abah and Daniel Ejeh Ukpabi and Juliana Ajuma Okoko},
      title   = {Prevalence of Hypertension Among Adolescents in Benue South, Nigeria},
      journal = {Journal of Hypertension and Cardiology},
      volume  = {3},
      number  = {4},
      pages   = {27--37},
      year    = {2025},
      issn    = {2329-9487},
      doi     = {10.14302/issn.2329-9487.jhc-25-5726},
      url     = {https://openaccesspub.org/hypertension-and-cardiology/article/prevalence-of-hypertension-among-adolescents-in-benue-south-nigeria-2229}
    }
  3. 研究論文

    Epidemiology, Clinical Profile and Short-Term Outcome of Hypertensive Crisis in N’Djamena (Chad)参考訳:ンジャメナ(チャド)における高血圧クリーゼの疫学、臨床像および短期転帰

    Naibé Dangwe Temoua, et al. 著者15名

    種別
    研究論文
    掲載日
    ページ
    16-26
    要旨(Epidemiology, Clinical Profile and Short-Term Outcome of Hypertensive Crisis in N’Djamena (Chad))

    Objective

    Hypertensive crisis is an increasingly frequent medical condition in our context. Its management in medical emergencies is a real challenge for physicians. Few data on hypertensive crisis are available in Chad. The aim of this study was to investigate the epidemiological, clinical and prognostic characteristics of hypertensive crisis in the medical emergency department of the Reference National Teaching Hospital in N’Djamena.

    Patients and methods

    This was a prospective cohort study running from 1 March 2020 to 31 October 2020. Patients presenting with a sudden and severe rise in blood pressure (systolic ≥ 180 mmHg and/or diastolic ≥ 110 mmHg) with or without acute target-organ damage were consecutively included and followed up over a period of one month. Epidemiological and clinical characteristics on admission, and morbidity and mortality parameters during the course of the disease, were collected. The Kaplan-Meier method and the Cox model were used to analyse survival and factors associated with death, with a significance level of p < 0.05.

    結果

    Of the 3978 hypertensive patients admitted to medical emergencies, 252 had a hypertensive crisis, i.e. a prevalence of 6.3%. Two hundred and seventeen (217) patients were included in the study, divided into 149 cases (69%) of hypertensive emergency and 67 cases (31%) of hypertensive urgency. The mean age of the patients was 55.2 ± 14 years (20 to 80 years) and 67% were male. Hypertension was known in 138 patients (64%). At least one complication was present on admission in 69% of patients. Complications were classified as cardiac (50.7%), neurological (38.2%), kidney impairment (46.5%) and ocular (46.1%). The average number of antihypertensive drugs used was 2 ± 0.83. Calcium antagonists (86.5%), diuretics (35.5%), converting enzyme inhibitors or angiotensin II receptor antagonists (33.3%) and beta-blockers (18%) were the pharmacological classes prescribed. Good compliance during follow-up was observed in 124 patients. One-month survival was 84% for all patients, with a 16% mortality rate. Factors associated with death were the duration of hypertension and the occurrence of cardiovascular, renal and ocular disease (p < 0.05).

    結論

    Hypertensive crisis is a frequent pathology in sub-Saharan Africa, with high morbidity and mortality. Prevention requires early detection and effective management of hypertension.

    引用方法
    Naibé Dangwe Temoua, et al. (2024). Epidemiology, Clinical Profile and Short-Term Outcome of Hypertensive Crisis in N’Djamena (Chad). Journal of Hypertension and Cardiology, 3(4), 16-26. https://doi.org/10.14302/issn.2329-9487.jhc-24-5040
    DOIからアクセス ↗

    著者一覧は省略しています。著者15名全員については全文をご覧ください。

    RIS/BibTeXを表示
    TY  - JOUR
    AU  - Naibé Dangwe Temoua
    TI  - Epidemiology, Clinical Profile and Short-Term Outcome of Hypertensive Crisis in N’Djamena (Chad)
    JO  - Journal of Hypertension and Cardiology
    SN  - 2329-9487
    VL  - 3
    IS  - 4
    SP  - 16
    EP  - 26
    PY  - 2024
    DA  - 2024-04-23
    DO  - 10.14302/issn.2329-9487.jhc-24-5040
    UR  - https://doi.org/10.14302/issn.2329-9487.jhc-24-5040
    PB  - Open Access Pub
    ER  - 
    @article{jhc2104,
      author  = {Naibé Dangwe Temoua},
      title   = {Epidemiology, Clinical Profile and Short-Term Outcome of Hypertensive Crisis in N’Djamena (Chad)},
      journal = {Journal of Hypertension and Cardiology},
      volume  = {3},
      number  = {4},
      pages   = {16--26},
      year    = {2024},
      issn    = {2329-9487},
      doi     = {10.14302/issn.2329-9487.jhc-24-5040},
      url     = {https://doi.org/10.14302/issn.2329-9487.jhc-24-5040}
    }
編集上の監督

本号の査読体制

JHCのすべての論文は、高血圧・循環器分野の専門家からなる国際的な編集委員会のもとで、シングルブラインド方式の査読(ご希望に応じてダブルブラインド方式)により評価されます。

編集委員会
現在の編集責任者
承認済みの役職、所属、および利用可能な識別子は、編集委員会のページで管理しています。
編集委員会を見る →
JHCに投稿する

高血圧・循環器分野の研究を本号とともに発表しませんか

CC BY 4.0によるオープンアクセス、恒久的なCrossref DOI、そして現役の循環器専門家で構成される委員会が運営するシングルブラインド方式の査読(ご希望に応じてダブルブラインド方式)。

APC USD 2,100・採択時に請求、全論文種別共通 投稿料 なし

本ページは英語版ジャーナルページの日本語版です。内容に相違がある場合は、英語版が優先されます。

メニュー

フォローする